$PH

Parker-Hannifin (PH) Q4 2026 Earnings Call Transcript

Parker-Hannifin (PH) reported fiscal 2026 record sales of $21.5B, up 6.6% organically, and adjusted EPS of $32.31, up 18%. Q4 sales rose to $5.8B and adjusted EPS to $9.27. Management set FY2027 guidance for 5.5% to 8.5% organic growth and $34.25 to $35.25 EPS, plus a 30% margin target by FY2031 and a $12.8B backlog.

Original reporting
Published Aug 13, 2026, 1:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Parker-Hannifin (PH) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$PHBullishMed
01

Why it matters

The most tradable elements are the FY2027 organic growth and adjusted EPS guidance ranges, the FY2031 margin target, and the stated acquisition closing conditions plus demand risk in agriculture.

02

Market read

Traders can update expectations for PH’s FY2027 growth, EPS, and margin trajectory based on management’s guidance and targets, while monitoring deal-clearance risk.

03

What to watch

Data center exposure is only 1.5% of sales, so investors may over-weight it; also, the shift to rolling 12-month order reporting could complicate near-term read-through versus prior metrics.

Relevance 7/10Novelty 6/10Timing: earnings call transcript, same-day positioning for FY2027 guidance

Background

Parker-Hannifin held its FY2026 Q4 and full-year earnings conference call, covering results, guidance, backlog, cash flow, and two pending acquisitions.

Company-level read

Ticker impact

$PHBullishMedium confidence
Context

Parker-Hannifin reported FY2026 record sales and EPS, plus FY2027 organic growth and adjusted EPS guidance, and reiterated pending acquisition conditions.

Expected impact

Likely positive bias for PH on guidance confidence, with volatility around regulatory clearance expectations for Filtration Group and CIRCOR aerospace.

Evidence & confidence

The transcript discloses multiple forward-looking datapoints (FY2027 growth and EPS range, FY2031 margin target, backlog) that can re-rate expectations, but it also flags regulatory clearance uncertainty and agriculture softness that could temper near-term demand.

Market effects

Signals strength in aerospace and industrial recovery, with thermal management/data center exposure still small but growing.

Highlights Asia Pacific organic growth acceleration, suggesting regional demand strength.

Backlog and margin targets reinforce global end-market resilience assumptions for industrial components.

Counterpoint

The agriculture softness warning and regulatory-clearance dependency for two deals could mean the upside is less durable than the headline margin targets imply.

Key entities

  • Parker-Hannifin Corporation

    Reported record FY2026 sales, EPS, margins, cash flow, backlog, and provided FY2027 guidance and long-term margin target.

  • Filtration Group Corporation

    Pending acquisition referenced as increasing filtration aftermarket exposure after closing, subject to regulatory clearance.

  • CIRCOR aerospace business

    Pending acquisition referenced as adding aerospace and defense technologies with high EBITDA margins before synergies, subject to regulatory clearance.

Related articles

$PHHighAI 8/10

Is Wall Street Bullish or Bearish on Parker-Hannifin Stock?

Parker-Hannifin (PH) reported Q4 2026 earnings with revenue of $5.8B, up 9.8% YoY, and adjusted EPS of $8.54, exceeding estimates. The stock has risen 36.8% over the past year, outperforming the S&P 500 and its industry benchmark. Analysts maintain a 'Strong Buy' consensus, with a mean price target of $1,175.38, suggesting a 17.5% upside.

$PHMedAI 9/10

Parker-Hannifin Corp (PH): Completion of Acquisition or Disposition of Assets

Parker-Hannifin Corp (PH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. 8-K Parker-Hannifin Corp false 0000076334 0000076334 2026-08-13 2026-08-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

$PHMed

The Top 5 Analyst Questions From Parker

Parker-Hannifin reported Q2 revenue of $5.76B vs $5.57B estimates and adjusted EPS of $9.27 vs $8.27, citing strong organic growth, aerospace momentum, and demand in electronics and in-plant markets. CEO Jennifer Parmentier said Filtration Group and CIRCOR acquisitions should close in H2, with integration plans ready. 2027 adjusted EPS guidance midpoint is $34.75.

$PHHighAI 8/10

Parker-Hannifin Q4 Earnings Call Highlights

Parker-Hannifin (NYSE:PH) reported Q4 orders up 19% versus the prior three-month period and 12% on a rolling 12-month basis, with backlog up 16% to a record $12.8B. North American industrial sales were $2.2B, aerospace sales $1.9B, and aerospace backlog $8.5B. The company set a new 30% adjusted segment operating margin target by fiscal 2031 and initiated FY2027 sales growth guidance of 5.5% to 8.5%.